1.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661
2.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198
3.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181
4.
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus
by Brunner, Hermine I
Pediatric nephrology (Berlin, West), 2018-08-29, Vol.34 (1), p.117-128
5.
Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients
by Zhang, Minmin
American journal of nephrology, 2014-09, Vol.40 (2), p.140-150
6.
The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch–Schönlein purpura nephritis
by Koskela, Mikael
Pediatric nephrology (Berlin, West), 2017-02-14, Vol.32 (7), p.1201-1209
7.
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
by Fabiano, Rafaela Cabral Gonçalves
Pediatric nephrology (Berlin, West), 2017-02-23, Vol.32 (7), p.1211-1220
8.
Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
by Hwang, Jin Ho
American journal of nephrology, 2016-12, Vol.44 (6), p.481-492
9.
Predictive ability of urinary biomarkers for outcome in children with acute kidney injury
by Mishra, Om P
Pediatric nephrology (Berlin, West), 2016-07-07, Vol.32 (3), p.521-527
10.
Oxidative Balance Score and Chronic Kidney Disease
by Ilori, Titilayo O
American journal of nephrology, 2015-11, Vol.42 (4), p.320-327
11.
Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents
by Kim, Siah
Pediatric nephrology (Berlin, West), 2016-06-23, Vol.32 (1), p.119-129
12.
Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria
by Tang, Xiaojing
American journal of nephrology, 2014-06, Vol.39 (5), p.376-382
13.
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
by Lambert, Nathan D., MD
The American heart journal, 2009, Vol.157 (4), p.688-694
14.
Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease
by Nakamura, Tsukasa
The American journal of the medical sciences, 2007-06, Vol.333 (6), p.321-326
15.
Kidney Function and Systolic Blood Pressure New Insights From Cystatin C: Data from the Heart and Soul Study
by Peralta, Carmen A
American journal of hypertension, 2006, Vol.19 (9), p.939-946
16.
Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction
by Martín-Granado, Ascensión
Pediatric nephrology (Berlin, West), 2009-04-01, Vol.24 (4), p.747-752
17.
Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease
by Lee, Yu-Ji
Postgraduate medical journal, 2011-10, Vol.87 (1032), p.664-669
18.
Levels of urinary transforming growth factor β-1 in children with D+ hemolytic uremic syndrome
by Caletti, María Gracia
Pediatric nephrology (Berlin, West), 2010-02-16, Vol.25 (6), p.1177-1180
19.
Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
by NAKAMURA, T
Diabetologia, 2007, Vol.50 (2), p.490-492
